Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7200
+0.0679 (10.41%)
At close: Jun 8, 2026, 4:00 PM EDT
0.7020
-0.0180 (-2.50%)
Pre-market: Jun 9, 2026, 5:37 AM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $29.41 million as of June 9, 2026. Its market cap has decreased by -18.08% in one year.
Market Cap
29.41M
Enterprise Value
-25.44M
1-Year Change
-18.08%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $29.41M, a decrease of -94.92%. That is a compound annual growth rate of -44.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 26.64M | -6.81% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 32.06M |
| Lisata Therapeutics | 31.43M |
| Evaxion | 31.11M |
| Apollomics | 30.74M |
| Aligos Therapeutics | 30.69M |
| IGC Pharma | 29.54M |
| Senti Biosciences Holdings | 29.33M |
| Serina Therapeutics | 28.31M |